Understanding the impact of combined TB and HIV diagnosis in diverse epidemics

Location

Canada, Canada

Dates

10/01/2012 - 03/01/2016

PI

David Dowdy, MD, PhD, ScM

We are developing models to understand the overlap of TB and HIV in three epidemiologically distinct settings (Canada, India, and Uganda), including the potential role of different combined diagnostic strategies, given the different breakdown of populations at high TB risk, high HIV risk, and high combined TB/HIV risk.

Projects

A smoking cessation trial in HIV/AIDS...

A tobacco prevalence survey and smoking cessation trial among HIV infected patients in South Africa.

Read More

Modeling to improve TB decision-making in the...

We are part of a large consortium that is constructing epidemic and economic models of TB and HIV in collaboration with the U.S....

Read More

The role of cell wall lipids in pathogenesis...

This study will use a combination of transcriptional, lipidomic, genetic, and imaging techniques to investigate whether...

Read More

FlexDx-TB: A flexible, user-friendly model of...

We have developed a web-based model that allows decision-makers to input local epidemiological and economic values and receive...

Read More